Browsing by Author "Randhir Kumar Yadav"

Now showing 1 - 3 of 3

Corrigendum to “PLGA nanoformulation of sparfloxacin enhanced antibacterial activity with photoprotective potential under ambient UV-R exposure” [Int. J. Pharm. 541 (2018) 173–187] (International Journal of Pharmaceutics (2018) 541(1–2) (173–187), (S0378517318301091) (10.1016/j.ijpharm.2018.02.028))
(Elsevier B.V., 2018) Jyoti Singh; Ashish Dwivedi; Lipika Ray; Deepti Chopra; Divya Dubey; Ajeet K. Srivastva; Smita Kumari; Randhir Kumar Yadav; Saroj Kumar Amar; Chandana Haldar; Ratan Singh Ray
The authors regret that mistakes related to image duplication, quality and labeling were found in Fig. 7b Fig. 9 Fig. 10 a. The corrected images are now provided as Figs. 7b, 9c, d and 10a. These mistakes do not change the scientific conclusions of the article in any way. The authors would like to apologise for any inconvenience caused. © 2018 Elsevier B.V.
Corrigendum to “PLGA nanoformulation of sparfloxacin enhanced antibacterial activity with photoprotective potential under ambient UV-R exposure” [Int. J. Pharm. 541 (2018) 173–187](S0378517318301091)(10.1016/j.ijpharm.2018.02.028)
(Elsevier B.V., 2019) Jyoti Singh; Ashish Dwivedi; Lipika Ray; Deepti Chopra; Divya Dubey; Ajeet K. Srivastva; Smita Kumari; Randhir Kumar Yadav; Saroj Kumar Amar; Chandana Haldar; Ratan Singh Ray
The authors regret to inform that there were inadvertent errors in some figures. The corrected images are given below. These corrections are not affecting the results and conclusion of the manuscript. Hence, the text in the original article remains unchanged. The corrected Fig. 8 is as follows: The corrected Fig. 12 is as follows: The authors would like to apologise for any inconvenience caused. © 2019 Elsevier B.V.
PLGA nanoformulation of sparfloxacin enhanced antibacterial activity with photoprotective potential under ambient UV-R exposure
(Elsevier B.V., 2018) Jyoti Singh; Ashish Dwivedi; Lipika Ray; Deepti Chopra; Divya Dubey; Ajeet K. Srivastva; Smita Kumari; Randhir Kumar Yadav; Saroj Kumar Amar; Chandana Haldar; Ratan Singh Ray
Sparfloxacin (SPFX) is a broad spectrum antibiotic which inhibits bacterial DNA gyrase enzyme activity. However, photodegradation in the presence of UVA limits its antibacterial activity and induces phototoxicity. Thus, to encounter this problem, we have developed poly d,l-lactic-co-glycolic acid (PLGA) loaded SPFX nanoparticles. Here, we have performed a comparative antibacterial activity of SPFX and its nanoparticles (NPs) through molecular docking and plate sensitivity assay. Under environmental UVA exposure, photoexcited SPFX significantly generates ROS, DNA damage and mitochondrial mediated cell death in comparison to PLGA-SPFX-NPs (nano SPFX) in human skin cell line (HaCaT). In presence of UVA, bulk SPFX induced cell cycle arrest with appearance of sub-G1 peak showing apoptosis while nano SPFX did not show any change. SPFX triggered apoptosis via alteration in membrane integrity of mitochondria and lysosome in comparison to PLGA-SPFX-NPs. Involvement of mitochondrial mediated cell death was confirmed by down-regulation of anti-apoptotic Bcl-2 and procaspase-3 and upregulation of pro-apoptotic Bax, cytochrome-c and caspase-3 proteins expression. Specific caspase inhibitor, Z-VAD-FMK showed involvement of caspase cascade pathway in apoptosis. Our finding suggests that controlled release of SPFX from PLGA-SPFX-NPs can reduce its side effects and enhance its antibacterial activity. Thus, nanotization of fluoroquinolones will be a significant step to reduce the problem of resistance and phototoxicity of this group. © 2018 Elsevier B.V.